Vendor, Menlo Park, CA
Vcreate, Inc.
UEI TDGANH2K4J93, CAGE 8NSH5
1 award and $355,000 obligated between February 8, 2024 and October 30, 2024, 100% under full and open competition, against 52.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $355,000 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91024C00001Definitive Contract, February 8, 2024, Full and Open Competition After Exclusion of Sources, 52 offers | NIH NCINational Institutes of Health | Concept SBIR - T-Cell Receptors for Treating Pediatric Acute Myeloid LeukemiaNAICS 541715, PSC AN12 | $355,000 |
- Places of performance
- California
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 2 across 1 awards